Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant
S. Maheshwari, A. Kassim, R. F. Yeh, J. Domm, C. Calder, M. Evans, B. Manes, K. Bruce, V. Brown, R. Ho, H. Frangoul, E. Yang
Dive into the research topics of 'Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant'. Together they form a unique fingerprint.